GENB in the 13F filings
Generate Biomedicines Inc · CUSIP 370920100
Q3 2026: 47 of 95 managers have filed so far; the filing deadline was 16 November 2026. Its figures cover those filers only, so it is not yet a picture of the tracked managers.
- Quarter end
- 30 Sep 2026
- the date the book describes
- Filed
- 16 Nov 2026
- latest of these filings; the earliest 9 Nov 2026
- Managers listing it
- 12
- at least, of 95 tracked, among listed positions
- Comparable managers
- 46
- filed both Q2 2026 and Q3 2026; 2 listed it in both
- Shares listed
- 15,965,119
- combined, among listed positions
- Reported value
- $240m
- combined, at the quarter end
Among the 89 comparable managers: 9 buyers (opened or added shares) and 5 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +2,927,894.
Managers listing GENB in Q3 2026
12 of 12 holders
Largest increases and reductions, by shares
Increases
- Fidelity (FMR LLC)existing position · 7,186,203 shares now+1,964,604
- ARK Investment Management LLCexisting position · 1,964,661 shares now+680,044
- Millennium Management LLCexisting position · 541,886 shares now+519,960
- Voloridge Investment Management LLCnew position · 362,138 shares now+362,138
- Two Sigma Investments LPexisting position · 205,195 shares now+186,821
Reductions
- T. Rowe Price Associates Incexisting position · 1,337,407 shares now-819,220
- Capital World Investorsexisting position · 4,201,990 shares now-13,642
- Invesco Ltdexisting position · 12,569 shares now-518
New positions and exits
New (3)
Exited (2)
- Renaissance Technologies LLCwas $669k
- Squarepoint Ops LLCwas $530k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q1 2026 | 2 | $56m | 12 | 0 |
| Q2 2026 | 2 | $93m | 9 | 8 |
| Q3 2026 | 3 | $98m | 9 | 5 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
GENB and LLY →GENB and TMO →GENB and JNJ →Choose a stock to compare with GENB →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own GENB, latest filings →Back to the 13F Explorer →